Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Liabilities (2016 - 2025)

CV Sciences' Total Liabilities history spans 15 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 10.4% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 10.4% decrease, with the full-year FY2025 number at $5.5 million, down 10.4% from a year prior.
  • Total Liabilities hit $5.5 million in Q4 2025 for CV Sciences, up from $5.5 million in the prior quarter.
  • Over the last five years, Total Liabilities for CVSI hit a ceiling of $18.7 million in Q1 2021 and a floor of $5.5 million in Q3 2025.
  • Historically, Total Liabilities has averaged $9.6 million across 5 years, with a median of $6.3 million in 2023.
  • Biggest five-year swings in Total Liabilities: grew 10.81% in 2022 and later plummeted 56.84% in 2023.
  • Tracing CVSI's Total Liabilities over 5 years: stood at $14.5 million in 2021, then fell by 6.95% to $13.5 million in 2022, then tumbled by 53.4% to $6.3 million in 2023, then decreased by 2.62% to $6.1 million in 2024, then decreased by 10.4% to $5.5 million in 2025.
  • Business Quant data shows Total Liabilities for CVSI at $5.5 million in Q4 2025, $5.5 million in Q3 2025, and $6.1 million in Q2 2025.